KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Dividends Paid - Common (2016 - 2026)

Medtronic (MDT) has disclosed Dividends Paid - Common for 13 consecutive years, with $911.0 million as the latest value for Q1 2026.

  • Quarterly Dividends Paid - Common rose 1.56% to $911.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.6 billion through Jan 2026, up 0.64% year-over-year, with the annual reading at $3.6 billion for FY2025, 2.1% down from the prior year.
  • Dividends Paid - Common hit $911.0 million in Q1 2026 for Medtronic, roughly flat from $910.0 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $918.0 million in Q3 2023 to a low of $843.0 million in Q2 2022.
  • Historically, Dividends Paid - Common has averaged $899.5 million across 5 years, with a median of $904.0 million in 2022.
  • Biggest five-year swings in Dividends Paid - Common: grew 8.45% in 2022 and later dropped 2.29% in 2024.
  • Year by year, Dividends Paid - Common stood at $904.0 million in 2022, then increased by 1.55% to $918.0 million in 2023, then fell by 2.29% to $897.0 million in 2024, then rose by 1.45% to $910.0 million in 2025, then grew by 0.11% to $911.0 million in 2026.
  • Business Quant data shows Dividends Paid - Common for MDT at $911.0 million in Q1 2026, $910.0 million in Q4 2025, and $910.0 million in Q3 2025.